Beneficial effect of 7-O-galloyl-d-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice

European Journal of Pharmacology

Volumn 640, Issue 1-3, 2010, Pages 233-242

  Park, Chan Hum ^a   Noh, Jeong Sook ^a   Yamabe, Noriko ^a   Kang, Ki Sung ^a   Tanaka, Takashi ^b   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

7 O Galloyl d sedoheptulose; Abnormal lipid metabolism; Advanced glycation endproduct; Db db mice; Inflammation; Kidney; Liver

Indexed keywords

7 O GALLOYL DEXTRO SEDOHEPTULOSE; ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; CARBOHYDRATE DERIVATIVE; CYCLOOXYGENASE 2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; 7-O-GALLOYL-D-SEDOHEPTULOSE; CHOLESTEROL; GLUCOSE; HEPTOSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DYSLIPIDEMIA; FLUID INTAKE; FOOD INTAKE; INFLAMMATION; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER FUNCTION; LIVER WEIGHT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BLOOD; BLOOD EXAMINATION; DRINKING; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DRINKING; GENE EXPRESSION REGULATION; GLUCOSE; HEMATOLOGIC TESTS; HEPTOSES; KIDNEY; LIVER; MALE; MICE; ORGAN SIZE; OXIDATIVE STRESS; TRIGLYCERIDES;

EID: 77953810606     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.028     Document Type: Article

References (57)

1. Ali S.F., LeBel C.P., Bondy S.C. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 1992, 13:637-648.
2. Aljada A., Garg R., Ghanim H., Mohanty P., Hamouda W., Assian E., Dandona P. Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?. J. Clin. Endocrinol. Metab. 2001, 86:3250-3256.
3. Amacher D.E. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul. Toxicol. Pharmacol. 1998, 27:119-130.
4. Avery N.C., Bailey A.J. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol. Biol. (Paris) 2006, 54:387-395.
5. Bierhaus A., Stern D.M., Nawroth P.P. RAGE in inflammation: a new therapeutic target?. Curr. Opin. Investig. Drugs 2006, 7:985-991.
6. Cammisotto P.G., Londono I., Gingras D., Bendayan M. Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats. Am. J. Physiol. Renal Physiol. 2008, 294:F881-F889.
7. Chang-Chen K.J., Mullur R., Bernal-Mizrachi E. Beta-cell failure as a complication of diabetes. Rev. Endocr. Metab. Disord. 2008, 9:329-343.
8. Chappey O., Dosquet C., Wautier M.P., Wautier J.L. Advanced glycation end products, oxidant stress and vascular lesions. Eur. J. Clin. Invest. 1997, 27:97-108.
9. Chiarelli F., Verrotti A., Mohn A., Morgese G. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications. Ann. Med. 1997, 29:439-445.
10. Cuzzocrea S., Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int. 2007, 71:290-297.
11. Eberhardt W., Pluéss C., Hummel R., Pfeilschifter J. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells. J. Immunol. 1998, 160:4961-4969.
12. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
13. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 1996, 271:9982-9986.
14. Gao L., Mann G.E. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82:9-20.
15. Hissin P.J., Hilf R.A. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
16. Ho E., Bray T.M. Antioxidants, NFκB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 1999, 222:205-213.
17. Hou D.X., Yanagita T., Uto T., Masuzaki S., Fujii M. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem. Pharmacol. 2005, 70:417-425.
18. Hyogo H., Yamagishi S. Advanced glycation end products (AGE) and their involvement in liver disease. Curr. Pharm. Des. 2008, 14:969-972.
19. Itzhaki R.F., Gill D.M.A. A micro-biuret method for estimating proteins. Anal. Biochem. 1964, 9:401-410.
20. Jayaprakasam B., Vareed S.K., Olson L.K., Nair M.G. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 2005, 53:28-31.
21. Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp. Clin. Endocrinol. Diabetes 2003, 111:246-250.
22. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26:439-451.
23. Kanková K., Kalousová M., Hertlová M., Krusová D., Olsovskỳ J., Zima T. Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene. Arch. Physiol. Biochem. 2008, 114:111-119.
24. Kanwar Y.S., Wada J., Sun L., Xie P., Wallner E.I., Chen S., Chugh S., Danesh F.R. Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood) 2008, 233:4-11.
25. Kotani K., Peroni O.D., Minokoshi Y., Boss O., Kahn B.B. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J. Clin. Invest. 2004, 114:1666-1675.
26. Lee J.I., Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 1998, 38:981-993.
27. Liou S.S., Liu I.M., Hsu S.F., Cheng J.T. Corni fructus as the major herb of Die-Huang-Wan for lowering plasma glucose in Wistar rats. J. Pharm. Pharmacol. 2004, 56:1443-1447.
28. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
29. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
30. Momose T., Yano Y., Ohashi K. Organic analysis. XLIV. A new deproteinizing agent for determination of blood sugar. Chem. Pharm. Bull. 1963, 11:968-972.
31. Naito C., Yamanaka T. Atherosclerosis and peroxidative lipid. Jpn. J. Geriatr. 1978, 15:187-191.
32. Nishikawa T., Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox Signal. 2007, 9:343-353.
33. O'Connor B.J., Kathamna B., Tavill A.S. Nonalcoholic fatty liver (NASH syndrome). Gastroenterologist 1997, 5:316-329.
34. Pergola C., Rossi A., Dugo P., Cuzzocrea S., Sautebin L. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide 2006, 15:30-39.
35. Ramasamy R., Vannucci S.J., Yan S.S., Herold K., Yan S.F., Schmidt A.M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16R-28R.
36. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
37. Srikanthan P., Hsueh W. Preventing heart failure in patients with diabetes. Med. Clin. North Am. 2004, 88:1237-1256.
38. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481:243-268.
39. Travlos G.S., Morris R.W., Elwell M.R., Duke A., Rosenblum S., Thompson M.B. Frequency and relationships of clinical chemistry and liver and kidney histopathology findings in 13-week toxicity studies in rats. Toxicology 1996, 107:17-29.
40. Tsuda T., Ueno Y., Kojo H., Yoshikawa T., Osawa T. Gene expression profile of isolated rat adipocytes treated with anthocyanins. Biochim. Biophys. Acta 2005, 15:137-147.
41. Unger R.H., Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985, 28:119-121.
42. Vareed S.K., Reddy M.K., Schutzki R.E., Nair M.G. Anthocyanins in Cornus alternifolia, Cornus controversa, Cornus kousa and Cornus florida fruits with health benefits. Life Sci. 2006, 78:777-784.
43. Wang T., Zhang X., Li J.J. The role of NF-κB in the regulation of cell stress responses. Int. Immunopharmacol. 2002, 2:1509-1520.
44. Wang Y., Zhou M., Lam K.S., Xu A. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arq. Bras. Endocrinol. Metabol. 2009, 53:201-212.
45. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E685-E694.
46. Winslow L.C., Kroll D.J. Herbs as medicines. Arch. Intern. Med. 1998, 158:2192-2199.
47. Yamabe N., Kang K.S., Goto E., Tanaka T., Yokozawa T. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol. Pharm. Bull. 2007, 30:520-526.
48. Yamabe N., Kang K.S., Matsuo Y., Tanaka T., Yokozawa T. Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 2007, 30:1289-1296.
49. Yamabe N., Kang K.S., Park C.H., Tanaka T., Yokozawa T. 7-O-Galloyl-d-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol. Pharm. Bull. 2009, 32:657-664.
50. Yamagishi S., Fukami K., Ueda S., Okuda S. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr. Drug Targets 2007, 8:952-959.
51. Yamakoshi J., Kataoka S., Koga T., Ariga T. Proanthocyanidin-rich extract of grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999, 142:139-149.
52. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 2007, 13:332-339.
53. Yang J., Craddock L., Hong S., Liu Z.M. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J. Cell. Biochem. 2009, 106:414-426.
54. Ye X., Krohn R.L., Liu W., Joshi S.S., Kuszynski C.A., McGinn T.R., Bagchi M., Preuss H.G., Stohs S.J., Bagchi D. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol. Cell. Biochem. 1999, 196:99-108.
55. Yim M.B., Yim H.S., Lee C., Kang S.O., Chock P.B. Protein glycation: creation of catalytic sites for free radical generation. Ann. N.Y. Acad. Sci. 2001, 928:48-53.
56. Yokozawa T., Park C.H., Noh J.S., Tanaka T., Cho E.J. Novel action of 7-O-galloyl-d-sedoheptulose isolated from Corni Fructus as a hypertriglyceridaemic agent. J. Pharm. Pharmacol. 2009, 61:653-661.
57. Younossi Z.M., Gramlich T., Matteoni C.A., Boparai N., McCullough A.J. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 2004, 2:262-265.